α-2-Macroglobulin in Saliva Is Associated with Glycemic Control in Patients with Type 2 Diabetes Mellitus

Figure 1

Box-plot showing the comparison of saliva levels of A2MG between patients with adequate and inadequate glycemic control (HbA1c percentages <7% and >7%).